News & Updates

IMT fast-tracks COVID-19 recovery

23 Sep 2021 by

Home-based inspiratory muscle training (IMT) – incorporated into COVID-19 rehabilitation programme – speeds up the recovery of patients in a UK study presented at ERS 2021.

IMT fast-tracks COVID-19 recovery

23 Sep 2021

Doxycycline not recommended for COVID-19 outpatient treatment in older adults

22 Sep 2021 by

Daily treatment with doxycycline did not shorten recovery time or reduce hospitalization or death in community-dwelling older adults with COVID-19, according to a study from the PRINCIPLE Collaborative Group.

Doxycycline not recommended for COVID-19 outpatient treatment in older adults

22 Sep 2021

Kids with asthma who are obese respond poorly to ICS

22 Sep 2021 by

Children with asthma are less likely to respond to inhaled corticosteroid (ICS) if they also happen to obese or overweight, suggests a study presented at ERS 2021.

Kids with asthma who are obese respond poorly to ICS

22 Sep 2021

COVID-19 booster gets FDA panel backing for 65 and up; blanket use shot down

22 Sep 2021 by

Advisers to the US FDA* unanimously voted for emergency use authorization (EUA) of the Pfizer/BioNTech COVID-19 vaccine booster dose in people 65 years and older and those at high risk of severe COVID-19.

COVID-19 booster gets FDA panel backing for 65 and up; blanket use shot down

22 Sep 2021

Secondhand smoke exposure ups kidney stone risk

21 Sep 2021

Exposure to secondhand smoke seems to increase the risk of developing kidney stone disease, a recent study has found.

Secondhand smoke exposure ups kidney stone risk

21 Sep 2021

Exercise during pregnancy tied to better lung function in babies

21 Sep 2021 by

Infants born to mothers who were inactive during pregnancy were more likely to have low lung function compared with those whose mothers were active while pregnant, according to the PreventADALL study presented at ERS 2021.

Exercise during pregnancy tied to better lung function in babies

21 Sep 2021

Inhaled budesonide may be effective for treating early COVID-19 in adults

21 Sep 2021 by

The administration of inhaled budesonide for the treatment of early COVID-19 in adults reduced the probability of needing urgent medical care and time to recovery, according to findings from the STOIC* trial presented at ERS 2021.

Inhaled budesonide may be effective for treating early COVID-19 in adults

21 Sep 2021

Pitolisant may manage residual sleepiness in OSA patients on CPAP

20 Sep 2021 by

The histamine H3-receptor antagonist/inverse agonist pitolisant showed a favourable risk-benefit profile in managing residual excessive daytime sleepiness (EDS) in individuals receiving continuous positive airway pressure (CPAP) for obstructive sleep apnoea (OSA), according to data from the HAROSA 1 trial presented at ERS 2021.

Pitolisant may manage residual sleepiness in OSA patients on CPAP

20 Sep 2021

Original New Drug Application Approvals by US FDA (01-15 September 2021)

20 Sep 2021

New drug applications approved by US FDA as of 01-15 September 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01-15 September 2021)

20 Sep 2021

Flu vaccine cuts all-cause, CV death risk in cardiac patients

17 Sep 2021 by

Receiving an influenza vaccination after hospitalization for an invasive coronary procedure or a myocardial infarction (MI) may reduce the risk of all-cause or cardiovascular (CV) death, according to results of the IAMI* trial.

Flu vaccine cuts all-cause, CV death risk in cardiac patients

17 Sep 2021

News & Updates

Filter by Specialty:

Specialty:

IMT fast-tracks COVID-19 recovery

IMT fast-tracks COVID-19 recovery

Doxycycline not recommended for COVID-19 outpatient treatment in older adults

Doxycycline not recommended for COVID-19 outpatient treatment in older adults

Kids with asthma who are obese respond poorly to ICS

Kids with asthma who are obese respond poorly to ICS

COVID-19 booster gets FDA panel backing for 65 and up; blanket use shot down

COVID-19 booster gets FDA panel backing for 65 and up; blanket use shot down

Secondhand smoke exposure ups kidney stone risk

Secondhand smoke exposure ups kidney stone risk

Exercise during pregnancy tied to better lung function in babies

Exercise during pregnancy tied to better lung function in babies

Inhaled budesonide may be effective for treating early COVID-19 in adults

Inhaled budesonide may be effective for treating early COVID-19 in adults

Pitolisant may manage residual sleepiness in OSA patients on CPAP

Pitolisant may manage residual sleepiness in OSA patients on CPAP

Original New Drug Application Approvals by US FDA (01-15 September 2021)

Original New Drug Application Approvals by US FDA (01-15 September 2021)

Flu vaccine cuts all-cause, CV death risk in cardiac patients

Flu vaccine cuts all-cause, CV death risk in cardiac patients